Friday, December 14, 2012
Alexza agitation drug gets EU recommendation, shares jump
Alexza agitation drug gets EU recommendation, shares jump: (Reuters) - European health regulators recommended approval of Alexza Pharmaceuticals Inc's experimental drug Adasuve for controlling agitation in adults with schizophrenia and bipolar disorder, sending its shares up 19 percent.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment